ReviewJournal of oral & maxillofacial research
Prevalence of Peri-implant Diseases in Patients with Osteoporosis: a Systematic Review.
Review in Journal of oral & maxillofacial research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This systematic review aimed to determine the prevalence of peri-implant diseases in patients affected by osteoporosis rehabilitated with dental implants. Material and Methods: An electronic search was conducted in the MEDLINE (PubMed), EMBASE, Scopus, and Web of Science databases up to April 2025, complemented by a manual search of the reference lists from the full-text studies. The search included observational studies that identified peri-implantitis and/or peri-implant mucositis in patients affected by osteoporosis rehabilitated with dental implants. The risk of bias was assessed using the Newcastle-Ottawa tool. Results: A total of 10, from 321, articles were included, and the reported evaluation periods after implant placement ranged from 3 to 11 years. Regardless of age, sex, number of implants, implant location, or duration of oral bisphosphonate use, all studies investigating the presence of mucositis and/or peri-implantitis reported no higher prevalence compared to systemically healthy patients. The prevalence of peri-implantitis was found to be 22%, and peri-implant mucositis 20%, in patients affected by osteoporosis. Conclusions: Within the limits of this systematic review, it is concluded that osteoporosis does not increase the prevalence of peri-implant diseases or dental implant failure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.